Alta Fundamental Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TDAY
USA Today Co
TDAY
|
+$10.6M |
| 2 |
MNK
Mallinckrodt plc
MNK
|
+$4.32M |
| 3 |
Indivior Pharmaceuticals
INDV
|
+$3.44M |
| 4 |
Neurogene
NGNE
|
+$73.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ODP
ODP
ODP
|
+$14.6M |
| 2 |
Hertz
HTZ
|
+$13.5M |
| 3 |
CWEN.A
Clearway Energy Class A
CWEN.A
|
+$13.1M |
| 4 |
JBGS
JBG SMITH
JBGS
|
+$5.7M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$3.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 37.6% |
| 2 | Consumer Discretionary | 20.47% |
| 3 | Communication Services | 14.39% |
| 4 | Miscellaneous | 11.58% |
| 5 | Energy | 8.71% |
Similar funds
Alta Fundamental Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, Alta Fundamental Advisers held 21 positions worth $206M, down 13% from $236M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Alta Fundamental Advisers withdrew a net $37.4M in Q2 2023, closing 8 positions and reducing 2 holdings. Its most notable exit was Hertz, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Materials at 38% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Alta Fundamental Advisers opened a new position in Indivior Pharmaceuticals worth $2.73M.
- Alta Fundamental Advisers's largest Q2 2023 buy was Indivior Pharmaceuticals: 150,000 shares worth $2.73M.
- Alta Fundamental Advisers added most to USA Today Co in Q2 2023, an estimated $10.6M increase.
- Alta Fundamental Advisers's biggest Q2 2023 reduction was ODP, cutting an estimated $14.6M.
- Alta Fundamental Advisers fully exited Hertz in Q2 2023, selling an estimated $13.5M.
- Alta Fundamental Advisers's ten largest holdings make up 98% of its $206M portfolio in Q2 2023.
- Alta Fundamental Advisers opened 3 new positions and closed 8 in Q2 2023.
- Alta Fundamental Advisers's portfolio value fell 13% quarter-over-quarter to $206M.
Based on Alta Fundamental Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.